2024 ICD-10-CM Diagnosis Code B55.2

by

Mucocutaneous leishmaniasis

  • B55.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM B55.2 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of B55.2 – other international versions of ICD-10 B55.2 may differ.

The following code(s) above B55.2 contain annotation back-references

 that may be applicable to B55.2:

  • A00-B99  Certain infectious and parasitic diseases
  • B50-B64  Protozoal diseases

Approximate Synonyms

  • Infection by leishmania braziliensis

Clinical Information

  • A disease characterized by the chronic, progressive spread of lesions from new world cutaneous leishmaniasis caused by species of the l. Braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.

ICD-10-CM B55.2 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 606 Minor skin disorders with mcc
  • 607 Minor skin disorders without mcc

Convert B55.2 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to B55.2: